Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss

Human Reproduction Update

Volumn 18, Issue 1, 2012, Pages 92-109

  Dahl, Mette ^a   Hviid, Thomas Vauvert F ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

Assisted reproduction; HLA class Ib; MHC; Pregnancy; Recurrent miscarriages

Indexed keywords

CELL RECEPTOR; CYTOKINE; HLA E ANTIGEN; HLA F ANTIGEN; HLA G ANTIGEN;

ARTICLE; DNA POLYMORPHISM; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFERTILITY; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RECURRENT DISEASE; SPONTANEOUS ABORTION; SUBFERTILITY;

EID: 83355175348     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmr043     Document Type: Article

References (156)

1. Abbas A, Tripathi P, Naik S, Agrawal S. Analysis of human leukocyte antigen (HLA)-G polymorphism in normal women and in women with recurrent spontaneous abortions. Eur J Immunogenet 2004;31:275-278.
2. Aldrich CL, Stephenson MD, Karrison T, Odem RR, Branch DW, Scott JR, Schreiber JR, Ober C. HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod 2001;7:1167-1172.
3. Apps R, Gardner L, Sharkey AM, Holmes N, Moffett A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol 2007;37:1924-1937.
4. Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends Immunol 2008a; 29:313-321.
5. Apps R, Gardner L, Traherne J, Male V, Moffett A. Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48. Hum Reprod 2008b;23:2535-2548.
6. Apps R, Murphy SP, Fernando R, Gardner L, Ahad T, Moffett A. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 2009;127:26-39.
7. + regulatory T cells during the follicular phase of the menstrual Cycle: implications for human reproduction. J Immunol 2007;178:2572-2578.
8. Arruvito L, Sotelo AI, Billordo A, Fainboim L. A physiological role for inducible FoxP3+ TReg cells: lessons from women with reproductive failure. Clin Immunol 2010;136:432-441.
9. Ashkar AA, Black GP, Wei Q, He H, Liang L, Head JR, Croy BA. Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J Immunol 2003;171:2937-2944.
10. Athanassakis I, Paflis M, Ranella A, Vassiliadis S. Detection of soluble HLA-G levels in maternal serum can be predictive for a successful pregnancy. Transplant Proc 1999; 31:1834-1837.
11. Avendano C, Franchi A, Jones E, Oehninger S. Pregnancy-specific beta-1-glycoprotein 1 and human leukocyte antigen-E mRNA in human sperm: Differential expression in fertile and infertile men and evidence of a possible functional role during early development. Hum Reprod 2009;24:270-277.
12. Berger DS, Hogge WA, Barmada MM, Ferrell RE. Comprehensive analysis of HLAG: implications for recurrent spontaneous abortion. Reprod Sci 2010;17:331-338.
13. Bhalla A, Stone PR, Liddell HS, Zanderigo A, Chamley LW. Comparison of the expression of human leukocyte antigen (HLA)-G and HLA-E in women with normal pregnancy and those with recurrent miscarriage. Reproduction 2006;131:583-589.
14. Billington WD. The immunological problem of pregnancy: 50 years with the hope of progress. A tribute to Peter Medawar. J Reprod Immunol 2003;60:1-11.
15. Borrego F, Kabat J, Sanni TB, Coligan JE. Cellular immunology and immune regulation-NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes. J Immunol 2002;169:6102-6111.
16. Boyle LH, Gillingham AK, Munro S, Trowsdale J. Selective export of HLA-F by its cytoplasmic tail. J Immunol 2006;176:6464-6472.
17. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human endometrium histochemical and immunohistochemical studies. Hum Reprod 1991;6:791-798.
18. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886.
19. Chen LJ, Han ZQ, Zhou H, Zou L, Zou P. Inhibition of HLA-G expression via RNAi abolishes resistance of extravillous trophoblast cell line TEV-1 to NK lysis. Placenta 2010;31:519-527.
20. Christiansen OB, Mohapeloa HP, Steffensen R, Jersild C. HLA-C and -Bw typing of couples with unexplained recurrent miscarriages. J Reprod Immunol 1997; 37:63-77.
21. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997;186:1809-1818.
22. Colonna M, Samaridis J, Cella M, Angman L, Allen L, O'Callaghan CA, Dunbar R, Ogg S, Cerundolo V, Rolink A. Cutting edge: hman myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998;160:3096-3100.
23. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA. Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood 2001;97:3146-3151.
24. Coulam CB. Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol 1991;26:23-27.
25. Desai N, Filipovits J, Goldfarb J. Secretion of soluble HLA-G by day 3 human embryos associated with higher pregnancy and implantation rates: assay of culture media using a new ELISA kit. Reprod BioMed Online 2006;13:272-277.
26. Ellis SA, Sargent IL, Redman CWG, McMichael AJ. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology 1986;59:595-601.
27. Favier B, LeMaoult J, Rouas-Freiss N, Moreau P, Menier C, Carosella ED. Research on HLA-G: an update. Tissue Antigens 2007;69:207-211.
28. Favier B, LeMaoult J, Lesport E, Carosella ED. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse. FASEB J 2010;24:689-699.
29. Flores AC, Marcos CY, Paladino N, Arruvito L, Williams F, Middleton D, Fainboim L. KIR receptors and HLA-C in the maintenance of pregnancy. Tissue Antigens 2007; 69:112-113.
30. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, Bencini E, Menicucci A, Baricordi OR. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002;32:311-315.
31. Geraghty DE, Wei X, Orr BT, Koller BH. Human leukocyte antigen F: an expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element. J Exp Med 1990;171:1-18.
32. Geraghty DE, Stockschleader M, Ishitani A, Hansen JA. Polymorphism at the HLA-E locus predatesmostHLA-A and -B polymorphism. Hum Immunol 1992;33:174-184.
33. + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 2005a;202:1075-1085.
34. + regulatory T cell proliferation. J Exp Med 2005b;202:919-929.
35. Gomez-Casado E, Martinez-Laso J, Vargas-Alarcon G, Varela P, Diaz-Campos N, Alvarez M, Alegre R, Arnaiz-Villena A. Description of a new HLA-E (E*01031) allele and its frequency in the Spanish population. Hum Immunol 1997;54:69-73.
36. Gomez-Lozano N, de Pablo R, Puente S, Vilches C. Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction. Eur J Immunol 2003;33:639-644.
37. Gonen-Gross T, Achdout H, Arnon TI, Gazit R, Stern N, Horejsi V, Goldman-Wohl D, Yagel S, Mandelboim O. The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta-2-microglobulin-free HLA-G molecules. J Immunol 2005;175:4866-4874.
38. Gregori S, Tomasoni D, Pacciani V, Scirpoli M, Battaglia M, Magnani CF, Hauben E, Roncarolo MG. Differentiation of type 1T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 2010; 116:935-944.
39. Grimsley C, Ober C. Population genetic studies of HLA-E. Evidence for selection. Hum Immunol 1997;52:33-40.
40. Gros F, Cabillic F, Toutirais O, Le Maux A, Sebti Y, Amiot L. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells. Eur J Immunol 2008;38:742-749.
41. + T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997;389:737-742.
42. Guillaudeux T, Gomez E, Onno M, Drenou B, Segretain D, Alberti S, Lejeune H, Fauchet R, Jegou B, Le Bouteiller P. Expression of HLA class I genes in meiotic and post-meiotic human spermatogenic cells. Biol Reprod 2006;55:99-110.
43. Harrison GA, Humphrey KE, Jakobsen IB, Cooper DW. A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet 1993;2:2200.
44. Heikkinen J, Mottonen M, Alanen A, Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol 2004;136:373-378.
45. Heinrichs H, Orr HT. HLA Non-A, -B, -C Class I genes, their structure and expression. Immunol Res 1990;9:265-274.
46. Hiby SE, Regan L, Lo W, Farrell L, Carrington M, Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod 2008;23:972-976.
47. Higuma-Myojo S, Sasaki Y, Miyazaki S, Sakai M, Siozaki A, Miwa N, Saito S. Cytokine profile of natural killer cells in early human pregnancy. Am J Reprod Immunol 2005; 54:21-29.
48. Hoare HL, Sullivan LC, Clements CS, Ely LK, Beddoe T, Henderson KN, Lin J, Reid HH, Brooks AG, Rossjohn J. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors. J Mol Biol 2008;377:1297-1303.
49. Hunt JS, Jadhav L, Chu W, Geraghty DE, Ober C. Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000;183:682-688.
50. Hunt JS, Pace JL, Morales PJ, Ober C. Immunogenicity of the soluble isoforms of HLA-G. Mol Hum Reprod 2003;9:729-735.
51. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 2005;19:681-693.
52. Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 2002;60:122-132.
53. Hviid TVF, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003;55:63-79.
54. Hviid TVF, Hylenius S, Lindhard A, Christiansen OB. Association between human leukocyte antigen-G genotype and success of in vitro fertilization and pregnancy outcome. Tissue Antigens 2004a;64:66-69.
55. Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004b;56:135-141.
56. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields protein with structures resembling both class I and II antigens. Proc Natl Acad Sci USA 1992; 89:3947-3951.
57. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, Geraghty DE. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003;171:1376-1384.
58. Jacobs R, Hintzen G, Kemper A, Beul K, Kempf S, Behrens G, Sykora KW, Schmidt RE. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol 2001;31:3121-3127.
59. Jasper MJ, Tremellen KP, Robertson SA. Primary unexplained infertility is associated with reduced expression of the T regulatory cell transcription factor FoxP3 in endometrial tissue. Mol Hum Reprod 2006;12:301-308.
60. Kanai T, Fujii T, Keicho N, Tokunaga K, Yamashita T, Hyodo H, Miki A, Unno N, Kozuma S, Taketani Y. Polymorphism of human leukocyte antigen-E gene in the Japanese population with or without recurrent abortion. Am J Reprod Immunol 2001;45:168-173.
61. King A, Boocock C, Sharkey A, Gardner L, Beretta A, Siccardi AG, Loke YW. Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J immunol 1996;16:2068-2076.
62. King A, Allan DSJ, Bowen M, Powis SJ, Joseph S, Verma S, Hiby SE, McMichael AJ, Loke YW, Braud VM. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 2000;30:1623-1631.
63. Klentzeris LD, Li TC, Dockery P, Cooke ID. The endometrial biopsy as a predictive factor of pregnancy rate in women with unexplained infertility. Eur J Obstet Gynecol Reprod Biol 1992;45:119-124.
64. Kunishima S, Nagae M, Mizuno S, Kamiya T, Ozawa K. A new polymorphism in the HLA-F gene 67Ala(GCC) to Ala(GCG). Immunogenetics 1999;49:147-148.
65. Kusumi M, Yamashita T, Fujii T, Nagamatsu T, Kozuma S, Taketani Y. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells. J Reprod Immunol 2006;70:33-42.
66. LaBonte ML, Letvin NL. Variable NKG2 expression in the peripheral blood lymphocytes of rhesus monkeys. Clin Exp Immunol 2004;138:205-212.
67. Lachapelle MH, Miron P, Hemmings R, Roy DC. Endometrial T B and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 1996;156:4027-4034.
68. Langat DK, Platt JS, Tawfik O, Fazleabas AT, Hunt JS. Differential expression of human leukocyte antigen-G (HLA-G) messenger RNAs and proteins in normal human prostate and prostatic adenocarcinoma. J Reprod Immunol 2006;71:75-86.
69. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998; 391:703-707.
70. Larsen MH, Bzorek M, Pass MB, Larsen LG, Nielsen MW, Svendsen SG, Lindhard A, Hviid TV. Human Leukocyte Antigen-G in the male reproductive system and in seminal plasma. Mol Hum Reprod, 2011; PMID 21813635.
71. Le Discorde M, Le Danff C, Moreau P, Rouas-Freiss N, Carosella ED. HLA-G*0105N null allele encodes functional HLA-G isoforms. Biol Reprod 2005;73:280-288.
72. Lee N, Geraghty DE. HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP. J Immunol 2003;171:5264-5271.
73. Lee RM, Silver RM. Recurrent pregnancy loss: Summary and clinical recommendations. Semin Reprod Med 2000;18:433-440.
74. Lee N, Goodlett DR, Ishitani A, Marquardt H, Geraghty DE. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 1998a;160:4951-4960.
75. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998b;95:5199-5204.
76. Lee N, Ishitani A, Geraghty DE. HLA-F is a surface marker on activated lymphocytes. Eur J Immunol 2010;40:2308-2318.
77. LeMaoult Jl., Zafaranloo Kl, Le Danff C, Carosella ED. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells NK cells, T cells. FASEB J 2005;19:662-664.
78. Lepin EJM, Bastin JM, Allan DSJ, Roncador G, Braud VM, Mason DY, van der Merwe PA, McMichael AJ, Bell JI, Powis SH et al. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur J Immunol 2000;30:3552-3561.
79. Llano M, Lee N, Navarro F, Garcia P, Albar JP, Geraghty DE, Lopez-Botet M. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol 1998;28:2854-2863.
80. Mclntire RH, Morales PJ, Petroff MG, Colonna M, Hunt JS. Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1. J Leukocyte Biol 2004;76:1220-1228.
81. Mendes-Junior CT, Castelli EC, Moreau P, Simoes AL, Donadi EA. Absence of the HLA-G*0113N allele in Amerindian populations from the Brazilian Amazon region. Hum Immunol 2010;71:428-431.
82. Ménézo Y, Elder K, Viville S. Soluble HLA-G release by the human embryo: An interesting artefact? Reprod BioMed Online 2006;13:763-764.
83. Miller JD, Weber DA, Ibegbu C, Pohl J, Altman JD, Jensen PE. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. J Immunol 2003;171:1369-1375.
84. Moesta AK, Norman PJ, Yawata M, Gleimer M, Parham P. Polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J immunol 2008;180:3669-3679.
85. Moffett-King A, Entrican G, Ellis S, Hutchinson J, Bainbridge D. Natural killer cells and reproduction. Trends Immunol 2002;23:332-333.
86. Morales PJ, Pace JL, Platt JS, Phillips TA, Morgan K, Fazleabas AT, Hunt JS. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol 2003;171:6215-6224.
87. Morales PJ, Pace JL, Platt JS, Langat K, Hunt JS. Synthesis of beta-2-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology 2007;122:179-188.
88. Morel E, Bellôn T. HLA class I molecules regulate IFN-g production induced in NK Cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j. J Immunol 2008;181:2368-2381.
89. Nagamatsu T, Fujii T, Matsumoto J, Yamashita T, Kozuma S, Taketani Y. Human leukocyte antigen F protein is expressed in the extra-villous trophoblasts but not on the cell surface of them. Am J Reprod Immunol 2006;56:172-177.
90. Naji A, Durrbach A, Carosella ED, Rouas-Freiss N. Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T cell alloproliferation through ILT-2/ILT-4/FasL-Mediated Pathways. Hum Immunol 2007;68:233-239.
91. Navarro F, Llano M, Bellôn T, Colonna M, Geraghty DE, Lôpez-Botet M. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 1999;29:277-283.
92. Noci I, Fuzzi B, Rizzo R, Melchiorri L, Criscuoli L, Dabizzi S, Biagiotti R, Pellegrini S, Menicucci A, Baricordi OR. Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod 2005;20:138-146.
93. Ober C, Aldrich C, Rosinsky B, Robertson A, Walker MA, Willadsen S, Verp MS, Geraghty DE, Hunt JS. HLA-G1 protein expression is not essential for fetal survival. Placenta 1998;19:127-132.
94. Ober C, Aldrich CL, Chervoneva I, Billstrand C, Rahimov F, Gray HL, Hyslop T. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003;72:1425-1435.
95. Ohya K, Kondo K, Mizuno S. Polymorphism in the human class I MHC Locus HLA-E in japanese. Immunogenetics 1990;32:205-209.
96. Parham P. The Immune System. New york, NY: Garland, 2005a.
97. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005b;5:201-214.
98. Pascale P, Cabestre FA, Ibrahim EC, Lefebvre S, Khalil-Daher I, Vazeux G, Quiles RM, Bermond F, Dausset J, Carosella ED. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5:-G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000a;61:1138-1149.
99. Pascale P, Rouas-Freiss N, Moreau P, Cabestre FA, Menier C, Khalil-Daher I, Pangault C, Onno M, Fauchet R, Martinez-Laso J et al. HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum Immunol 2000b;61:1177-1195.
100. Penzes M, Rajczy K, Gyodi E, Reti M, Feher E, Petranyi G. HLA-G gene polymorphism in the normal population and in recurrent spontaneous abortion in Hungary. Transplant Proc 1999;31:1832-1833.
101. Pfeiffer KA, Rebmann V, Pässler M, van der Ven K, van der Ven H, Krebs D, Grosse-Wilde H. Soluble HLA levels in early pregnancy after in vitro fertilization. Hum Immunol 2000;61:559-564.
102. Pfeiffer KA, Fimmers R, Engels G, van der Ven H, van der Ven K. Implantation and Pregnancy. The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol Hum Reprod 2001;7:373-378.
103. Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, Vitale C, Bertone S, Moretta A, Moretta L, Mingari MC. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA 1999;96:5674-5679.
104. Rajagopalan S, Long EO. A Human Histocompatibility Leukocyte Antigen (HLA)-Gspecific receptor expressed on all natural killer cells. J Exp Med 1999; 189:1093-1100.
105. Rebmann V, Pfeiffer K, Pässler M, Ferrone S, Maier S, Weiss E, Grosse-Wilde H. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999;53:14-22.
106. Rebmann V, Switala M, Eue I, Schwahn E, Merzenich M, Grosse-Wilde H. Rapid evaluation of soluble HLA-G levels in supernatants of in vitro fertilized embryos. Hum Immunol 2007;68:251-258.
107. Rebmann V, Switala M, Eue I, Grosse-Wilde H. Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: a German multi-centre study. Hum Reprod 2010;25:1691-1698.
108. Rizzo R, Andersen AS, Lassen MR, Sorensen HC, Bergholt T, Larsen MH, Melchiorri L, Stignani M, Baricordi OR, Hviid TV. Soluble Human Leukocyte Antigen-G isoforms in maternal plasma in early and late pregnancy. Am J Reprod Immunol 2009;62:320-338.
109. Roussev RG, Coulam CB. HLA-G and its role in implantation (review). J Assist Reprod Genet 2007;24:288-295.
110. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion-insertion polymorphism in the 3'UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003;64:1005-1010.
111. Sageshima N, Shobu T, Awai K, Hashimoto H, Yamashita M, Takeda N, Odawara Y, Nakanishi M, Hatake K, Ishitani A. Soluble HLA-G is absent from human embryo cultures: a reassessment of sHLA-G detection methods. J Reprod Immunol 2007; 75:11-22.
112. Saito S, Nishikawa K, Morii T, Enomoto M, Narita N, Motoyoshi K, Ichijo M. Cytokine production by CD16-CD56bright natural killer cells in the human early pregnant decidua. Int Immunol 1993;5:559-563.
113. + regulatory T cells in self-tolerance and autoimmune disease. Curr Top Microbiol Immunol 2006;305:51-66.
114. + regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004;10:347-353.
115. + T lymphocytes in early human pregnancy. Biol Reprod 2006;75:562-567.
116. Schorge J. Williams' Gynecology. New York: McGraw-Hill Medical, 2008.
117. + regulatory T cells. Stem cells 2008;26:212-222.
118. Shaikly VR, Morrison IEG, Taranissi M, Noble CV, Withey AD, Cherry RJ, Blois SM, Fernàndez N. Analysis of HLA-G in maternal plasma, follicular fluid, preimplantation embryos reveal an asymmetric pattern of expression. J Immunol 2008;180:4330-4337.
119. Shaikly V, Shakhawat A, Withey A, Morrison I, Taranissi M, Dealtry GB, Jabeen A, Cherry R, Fernández N. Cell bio-imaging reveals co-expression of HLA-G and HLA-E in human preimplantation embryos. Reprod BioMed Online 2010; 20:223-233.
120. Sher G, Keskintepe L, Nouriani M, Roussev R, Batzofin J. Expression of sHLA-G in supernatants of individually cultured 46-h embryos. Reprod Biomed Online 2004; 9:74-78.
121. Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, Allan DSJ, Makadzange A, Rowland-Jones S, Willcox B et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 2003;100:8856-8861.
122. Shiroishi M, Kuroki K, Ose T, Rasubala L, Shiratori I, Arase H, Tsumoto K, Kumagai I, Kohda D, Maenaka K. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem 2006; 281:10439-10447.
123. Shobu T, Sageshima N, Tokui H, Omura M, Saito K, Nagatsuka Y, Nakanishi M, Hayashi Y, Hatake K, Ishitani A. The surface expression of HLA-F on decidual trophoblasts increases from mid to term gestation. J Reprod Immunol 2006; 72:18-32.
124. Sipak-Szmigiel O, Ronin-Walknowska E, Cybulski C, Plonka T, Lubinski J. Antigens HLA-G, sHLA- G and sHLA- class I in reproductive failure. Folia Histochem Cytobiol 2007;45:137-141.
125. Sipak-Szmigiel O, Cybulski C, Lubinski J, Ronin-Walknowska E. HLA-G polymorphism in a Polish population and reproductive failure. Tissue Antigens 2008;71:67-71.
126. Solier C, Aguerre-Girr M, Lenfant F, Campan A, Berrebi A, Rebmann V, Grosse-Wilde H, Le Bouteiller P. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 2002; 32:3576-3586.
127. Starkey PM, Clover LM, Rees MCP. Variation during the menstrual cycle of immune cell populations in human endometrium. Eur J Obstet Gynecol Reprod Biol 1991; 39:203-207.
128. Steffensen R, Christiansen OB, Bennett EP, Jersild C. HLA-E polymorphism in patients with recurrent spontaneous abortion. Tissue Antigens 1998;52:569-572.
129. Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A, Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol 2007;57:277-286.
130. Strong RK, Holmes MA, Li P, Braun L, Lee N, Geraghty DE. HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem 2003;278:5082-5090.
131. Suarez MB, Morales P, Castro MJ, Fernandez V, Varela P, Alvarez M, Martinez-Laso J, Arnaiz-Villena A. A new HLA-G allele (HLA-G*0105N) and its distribution in the Spanish population. Immunogenetics 1997;45:464-465.
132. Suryanarayana V, Rao L, Kanakavalli M, Padmalatha V, Raseswari T, Deenadayal M, Singh L. Association between novel HLA-G genotypes and risk of recurrent miscarriages: a case-control study in a south indian population. Reprod Sci 2008;15:817-824.
133. Tabiasco J, D'Hauterive SP, Thonon F, Parinaud J, Léandri R, Foidart JM, Chaouat G, Munaut C, Lombroso R, Selva J et al. Soluble HLA-G in IVF/ICSI embryo culture supernatants does not always predict implantation success: a multicentre study. Reprod Biomed Online 2009;18:374-381.
134. Tripathi P, Abbas A, Naik S, Agrawal S. Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens 2004;64:706-710.
135. Tripathi P, Naik S, Agrawal S. HLA-E and immunobiology of pregnancy. Tissue Antigens 2006;67:207-213.
136. Trundley A, Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens 2004;63:1-12.
137. Uchigiri C, Mizuno S, Wada K, Tsutsumi M, Kato T, Kamiya T, Ozawa K. An identification of the HLA-F null allele in Japanese. Immunogenetics 1997; 45:466-467.
138. Uemura Y, Suzuki M, Liu TY, Narita Y, Hirata S, Ohyama H, Ishihara O, Matsushita S. Role of human non-invariant NKT lymphocytes in the maintenance of type 2 T helper environment during pregnancy. Int Immunol 2008;20:405-412.
139. Vales-Gomez M, Reyburn HT, Erskine RA, Lopez-Botet M, Strominger JL. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2A and the activating receptor CD94/NKG2C to HLA-E. EMBO J 1999; 18:4250-4260.
140. Vercammen MJ, Verloes A, Van de Velde H, Haentjens P. Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis. Hum Reprod Update 2008;14:209-218.
141. Verma S, King A, Loke YW. Expression of killer cell inhibitory receptors on human uterine natural killer cells. Eur J Immunol 1997;27:979-983.
142. Wainwright SD, Biro PA, Holmes CH. Molecular and structural immunolgy-HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern. J Immunol 2000;164:319.
143. Wang S, Zhao YR, Jiao YL, Wang LC, Li JF, Cui B, Xu CY, Shi YH, Chen ZJ. Increased activating killer immunoglobulin-like receptor genes and decreased specific HLA-C alleles in couples with recurrent spontaneous abortion. Biochem Biophys Res Commun 2007;360:696-701.
144. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Trends Immunol 1993;14:353-356.
145. Wei-hua Y, Aifen L, Bao-guo C, Mei-ying Z, Mei-zhen D, Xue-jiao C, Ling-hong G, Min Z, Wei-wu S, Bo-li L. Possible roles of KIR2DL4 expression on uNK cells in human pregnancy. Am J Reprod Immunol 2007;57: 233-242.
146. Witt CS, Goodridge J, Gerbase-Delima MG, Daher S, Christiansen FT. Maternal KIR repertoire is not associated with recurrent spontaneous abortion. Hum Reprod 2004;19:2653-2657.
147. Xue S, Yang J, Yao F, Xu L, Fan L. Recurrent spontaneous abortions patients have more 214 bp/+14 bp heterozygotes in the 3'UT region of the HLA-G gene in a Chinese Han population. Tissue Antigens 2007;69:153-155.
148. + T cells in patients with history of recurrent abortion. J Reprod Immunol 1998;38:63-73.
149. + T cells in decidual and peripheral lymphocytes of normal pregnancy and spontaneous abortion with and without history of recurrent abortion. Am J Reprod Immunol 1999;42:355-360.
150. Yamashita T, Fujii T, Tokunaga K, Tadokoro K, Hamai Y, Miki A, Kozuma S, Juji T, Taketani Y. Analysis of human leukocyte antigen-G polymorphism including intron 4 in Japanese couples with habitual abortion. Am J Reprod Immunol 1999; 41:159-163.
151. Yan WH, Fan LA, Yang JQ, Xu LD, Ge Y, Yao FJ. HLA-G polymorphism in a Chinese Han population with recurrent spontaneous abortion. Int J Immunogenet 2006a;33:55-58.
152. Yan WH, Lin A, Chen XJ, Dai MZ, Gan LH, Zhou MY, Zhu M, Shi WW, Liu JM. Association of the maternal 14-bp insertion polymorphism in the HLA-G gene in women with recurrent spontaneous abortions. Tissue Antigens 2006b;68:521-523.
153. Yie SM, Balakier H, Motamedi G, Librach CL. Secretion of human leukocyte antigen-G by human embryos is associated with a higher in vitro fertilization pregnancy rate. Fertil Steril 2005;83:30-36.
154. Yu YR, Tian XH, Wang Y, Feng MF. Rapid production of human KIR2DL4 extracellular domain and verification of its interaction with HLA-G. Biochemistry 2006;71:60-64.
155. Zhang M, Weng X, Liang Z, Lu S, Li J, Chen X, Li Q, Sun W, Song Y, Shen G et al. Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T cell alloresponse. Transplantation 2009;87:8-15.
156. Zhu Y, Huo Z, Lai J, Li S, Jiao H, Dang J, Jin C. Case-control study of a HLA-G 14-bp insertion-deletion polymorphism in women with recurrent miscarriages. Scand J Immunol 2010;71:52-54.